% Expired Patents = 100.0

EPO Patents = 4

Forward Citations = 12

Loading Chart...

11 inventors (with patents filed for the assignee):

Guillermo Gimenez Gallego (3 out of 19 patents)

Antonio Romero Garrido (3 out of 17 patents)

Pedro Cuevas Sànchez (2 out of 16 patents)

4. Javier Angulo Frutos (2 out of 16 patents)

5. Serafin Valverde Lopez (2 out of 17 patents)

6. Rosa Maria Lozano Puerto (2 out of 17 patents)

7. Pedro Cuevas Sánchez (1 out of 9 patents)

8. Inigo Saenz De Tejada Morgan (1 out of 1 patent)

9. Inigo Saenz De Tejada Morgan (1 out of 5 patents)

10. Serafín Valverde Lopez (1 out of 1 patent)

11. Rosa María Lozano Puerto (1 out of 1 patent)

12. Luis Ignacio Rivas López (0 patent)

13. Guillermo Giménez Gallego (0 patent)

14. Iñigo Sáenz De Tejada Gorman (0 patent)

15. Serafín Valverde López (0 patent)

3 patents: Sort by Forward Citations

1. 9248114 - Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ (2016-02-02),

2. 8541467 - Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ (2013-09-24),

3. 7968531 - Use of 2,5-dihydroxybenzenesulphonic acid in the production of medicaments for the treatment of angiodependent diseases such as cancer and psoriasis (2011-06-28),

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

3 Patents

#100 in Madrid

#661 in Spain

Madrid, Spain

Action Medicines, S.l.

Forward Citations = 12

11 inventors:

Guillermo Gimenez Gallego (3 out of 19 patents)

Antonio Romero Garrido (3 out of 17 patents)

Pedro Cuevas Sànchez (2 out of 16 patents)

4. Javier Angulo Frutos (2 out of 16 patents)

5. Serafin Valverde Lopez (2 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Action Medicines, S.l.. Retrieved from https://idiyas.com/company/action-medicines-s-l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]